Barrington Research Reaffirms Outperform Rating for Henry Schein (NASDAQ:HSIC)

Henry Schein (NASDAQ:HSIC)‘s stock had its “outperform” rating reaffirmed by stock analysts at Barrington Research in a research report issued on Wednesday,Benzinga reports. They presently have a $82.00 price objective on the stock. Barrington Research’s price objective would indicate a potential upside of 18.10% from the company’s current price. Barrington Research also issued estimates for Henry Schein’s Q4 2024 earnings at $1.20 EPS, FY2024 earnings at $4.75 EPS, Q1 2025 earnings at $1.12 EPS, Q2 2025 earnings at $1.26 EPS, Q3 2025 earnings at $1.27 EPS, Q4 2025 earnings at $1.46 EPS, FY2025 earnings at $5.12 EPS and FY2026 earnings at $5.80 EPS.

Several other equities research analysts have also recently issued reports on HSIC. StockNews.com cut shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Evercore ISI upped their target price on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. UBS Group dropped their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $77.50.

Henry Schein Trading Down 0.8 %

HSIC opened at $69.43 on Wednesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. The company’s 50 day simple moving average is $70.56 and its two-hundred day simple moving average is $69.78. Henry Schein has a 1-year low of $62.12 and a 1-year high of $82.63. The firm has a market capitalization of $8.80 billion, a price-to-earnings ratio of 25.71, a price-to-earnings-growth ratio of 2.08 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.32 EPS. Analysts expect that Henry Schein will post 4.74 EPS for the current fiscal year.

Insider Transactions at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 1.14% of the company’s stock.

Hedge Funds Weigh In On Henry Schein

Several hedge funds have recently made changes to their positions in HSIC. Empirical Finance LLC boosted its holdings in shares of Henry Schein by 3.5% during the first quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock worth $360,000 after purchasing an additional 160 shares during the period. Cromwell Holdings LLC increased its holdings in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares during the period. Covestor Ltd increased its holdings in Henry Schein by 12.8% in the 1st quarter. Covestor Ltd now owns 1,511 shares of the company’s stock valued at $114,000 after buying an additional 171 shares during the period. Simplify Asset Management Inc. increased its holdings in Henry Schein by 5.0% in the 2nd quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock valued at $237,000 after buying an additional 175 shares during the period. Finally, Sequoia Financial Advisors LLC grew its holdings in shares of Henry Schein by 3.2% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock worth $364,000 after purchasing an additional 176 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.